Approved Study Database

Ref. No. Scientific Title Principal investigator
2018.474 Randomized phase II study of combination androgen deprivation therapy (ADT) and radiotherapy in high risk prostate cancer: Stereotactic body Radiotherapy vs conventionAl IMRT to prostate and pelvic nodes (SRAM study) Dr. POON Darren M.C.
2019.411 The Excessive Mortality in Nasopharyngeal Carcinoma (NPC) Survivors ≥ 5 years Dr. POON Darren M.C.
潘明駿
2019.528 Stratification of Indolent Versus Aggressive Prostate Cancer plus the Determination of Druggable Gene Targets for Aggressive Prostate Cancer: A Retrospective Study Using Archival Biopsy Samples Dr. POON Darren M.C.
2019.649 PSMA-PET guided Stereotactic Ablative Body Radiotherapy for Oligometastasis in metastatic castration-resistant prostate cancer (mCRPC) with progression on Enzalutamide (PMSABR study) Dr. POON Darren MC
潘明駿
2018.472 A Phase 2, Randomized, Open-label Study of Nivolumab or Nivolumab/BMS-986205 Alone or Combined with Intravesical BCG in Participants with BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer (CheckMate 9UT: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 9UT) Dr. POON Darren Ming Chun
潘明駿
2020.055 An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants with Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies Dr. POON Darren Ming Chun
2018.459 Retrospective study of docetaxel-related neutropenic sepsis in metastatic hormonal-sensitive prostate cancer (mHSPC) and metastatic castration-resistant prostate cancer (mCRPC) Dr. POON Darren Ming Chun
潘明駿
2019.333 A Randomized, Double-Blind, Controlled Phase 3 Study of Cabozantinib in Combination with Nivolumab and Ipilimumab versus Nivolumab and Ipilimumab in Subjects with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma of Intermediate or Poor Risk Dr. POON Darren Ming Chun
潘明駿
2019.613 A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer (CheckMate 7DX: CHECKpoint pathway and nivoluMAB clinical Trial Evaluation 7DX) Dr. POON Darren Ming Chun
潘明駿
2011.603 A PHASE III STUDY OF POSTOPERATIVE RADIATION THERAPY (IMRT) +/- CETUXIMAB FOR LOCALLY-ADVANCED RESECTED HEAD AND NECK CANCER Dr. POON Darren Ming Chun
2018.036 A randomized, open label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877)compared to chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma who have received prior platinumcontaining chemotherapy Dr. POON Darren Ming Chun
潘明駿醫生
2016.347 Phase II Trial of Pembrolizumab (MK-3475) in Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-199) Dr. POON Darren Ming Chun
潘明駿醫生
2016.302 A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB (ANTI−PD-L1 ANTIBODY) AS MONOTHERAPY AND IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA Dr. POON Darren Ming Chun
潘明駿
2017.067 Study on Epidemiology and Clinical Features of Patients Diagnosed with Nasopharyngeal Carcinoma at less than 20 years old in Hong Kong from 1993-2012 Dr. POON Darren Ming Chun
潘明駿
2019.630 Survival Estimate Models of Cancer Patients with Spinal Metastases: Big Data Analytics to Aid Daily Clinical Practice Dr. POON Darren Ming Chun
潘明駿
2022.312 Cardiovascular investigation of Coronavirus Disease 2019 (COVID-19) Prof. POON Ellen
潘雅欣
2024.410 Effects of High-Intensity Interval Training on Cardiometabolic, Cognitive and Mental Health in Hong Kong Adolescents with Intellectual Disabilities: A Cluster-Randomized Controlled Trial Prof. POON Eric Tsz Chun
Eric Tsz-chun Poon
2024.355 High-Intensity Interval Exercise and Low-Carbohydrate Diet for Glycaemic Control and Cardiovascular Fitness in Physically Inactive Adults with Prediabetes: A Comparative Randomised Trial Prof. POON Eric Tsz Chun
潘梓竣
2015.104 Prospective cohort study of the difference in physical fitness of first team players and the bench players throughout a game season in soccer Mr Poon Hiu Kong Alfred
2007.456 An Uncontrolled Observational Study to Monitor Vascular Access on Haemodilaysis Patients in One Single Centre RN Poon Ka Lai
2024.206 The effectiveness of relaxing music during antenatal ultrasound among high-risk pregnant women to reduce antenatal anxiety. Prof. POON Liona Chiu Yee
Chiu Yee Liona POON
2019.484 Validation of Preeclampsia Detection kit (Point-of-Care test) Prof. POON Liona Chiu Yee
潘昭頤
2020.473 Genome-wide cell-free DNA test for fetal chromosomal abnormalities and genomic aberrations Prof. POON Liona Chiu Yee
潘昭頤
2020.468 Pregnancy and Neonatal Outcomes in COVID-19: A global registry of women with suspected COVID-19 or confirmed SARS-CoV-2 infection in pregnancy and their neonates; understanding natural history to guide treatment and prevention Prof. POON Liona Chiu Yee
潘昭頤
2018.410 Novel Technique for the Detection of Fetal Cells in Maternal Circulation Prof. POON Liona Chiu Yee
潘昭頤
2018.302 Evaluation of aspirin non-responsiveness in preeclampsia prevention: a pharmacometabolomic approach Prof. POON Liona Chiu Yee
潘昭頤
2020.214 COVID-19 seroconversion during pregnancy Prof. POON Liona Chiu Yee
潘昭頤
2020.245 MIND-COVID: Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic – a web-based cross-sectional survey Prof. POON Liona Chiu Yee
潘昭頤
2018.391 Implementation of first-trimester screening and prevention of preeclampsia: a stepped wedge cluster-randomized trial in Asia Prof. POON Liona Chiu Yee
潘昭頤
2018.622 Genetics association and neurodevelopment in fetal congenital abnormalities Prof. POON Liona Chiu Yee
潘昭頤
2020.210 Effect of coronavirus disease 2019 (COVID-19) on maternal and perinatal outcomes and risk of vertical transmission Prof. POON Liona Chiu Yee
潘昭頤
2020.690 Prenatal neurosonography in monochorionic twins Prof. POON Liona Chiu Yee
潘昭頤
2018.019 Placenta immune cells characterization in pregnancy complications Prof. POON Liona Chiu Yee
2017.173 Gestational normal values of Sylvian angle at 14-36 weeks’ gestation Prof. POON Liona Chiu Yee
潘昭頤
2016.338 Ultrasound-based partogram for assessment of progress in labour Prof. POON Liona Chiu Yee
潘昭頤
2017.472 Study on “Biomarkers in the prediction of placental complications in pregnancy from assisted reproductive technology” Prof. POON Liona Chiu Yee
潘昭頤
2017.473 Study on "Evaluation of Maternal and Fetal Dopplers" Prof. POON Liona Chiu Yee
潘昭頤
2017.496 Cervicovaginal Fluid Biomarker for the Identification of Spontaneous Preterm Birth Prof. POON Liona Chiu Yee
潘昭頤
2016.292 Maternal cardiac function in high-risk pregnancies with impaired placentation Prof. POON Liona Chiu Yee
潘昭頤
2016.594 Vaginal Progesterone for the Prevention of Preterm birth in Twins: A pilot randomised, factorial designed trial – ‘POPPET’ Prof. POON Liona Chiu Yee
潘昭頤
2017.578 The Use of Semi-automated Blood Pressure Device for Early Detection of Preeclampsia and Home Monitoring Prof. POON Liona Chiu Yee
潘昭儀
2021.247 Integration of ultrasound into partogram for assessment of progress in labour Prof. POON Liona Chiu Yee
潘昭頤
2022.034 First-trimester preeclampsia screening: psychological impact on pregnant women throughout pregnancy Prof. POON Liona Chiu Yee
潘昭頤
2023.559 Validation of the Fetal Medicine Foundation first-trimester Bayes theorem-based model for the prediction of preeclampsia: an individual-patient-data meta-analysis (FMF-IPDMA) Prof. POON Liona Chiu Yee
2021.249 Labor induction versus expectant management in high-risk women for preeclampsia (FORECAST-IOL) Prof. POON Liona Chiu Yee
2023.231 The Application of Urine Specimen for Women Wellness Prof. POON Liona Chiu Yee
2021.406 Aspirin versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial 早发型子痫前期高风险孕妇使用阿司匹林与二甲双胍的比较: 一项三臂随机对照试验 Prof. POON Liona Chiu Yee
潘昭頤
2022.467 Evaluation of first trimester screening performance and cost effectiveness Prof. POON Liona Chiu Yee
2022.340 First-trimester screening and prevention of preeclampsia: prenatal and postpartum follow-up Prof. POON Liona Chiu Yee
2022.445 A point-of-care test for the measurement of placental growth factor for preeclampsia risk stratification Prof. POON Liona Chiu Yee

Page 182 of 254.